Announcement on Abnormal Stock Trading Fluctuations

Pacific Shuanglin Bio-pharmacy Co., Ltd.·June 22, 2026·2 pages

✨ AI Summary

This announcement addresses the abnormal trading fluctuations of Pais Shuanglin Bio-Pharmaceutical Co., Ltd. stock, which experienced a cumulative price drop exceeding 20% over three trading days. The company has investigated and confirmed no undisclosed material information that would impact stock price, other than a previously announced termination of a control transfer matter. Production and operations are normal, and no insider trading occurred.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 000403 Securities Abbreviation: Pais Shuanglin Announcement No.: 2026-040 Pais Shuanglin Bio-Pharmaceutical Co., Ltd. Announcement on Abnormal Stock Trading Fluctuations

The Company and the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and that there are no false records, misleading statements, or material omissions.

I. Situation of Abnormal Stock Trading Fluctuations

Pais Shuanglin Bio-Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") experienced abnormal stock trading fluctuations, with the cumulative closing price deviation exceeding 20% over three consecutive trading days (June 17, 2026, June 18, 2026, and June 22, 2026). In accordance with the relevant regulations of the Shenzhen Stock Exchange, this constitutes abnormal stock trading fluctuations.

II. Company's Attention and Verification

Regarding the abnormal stock trading fluctuations of the Company's stock, the Company has investigated relevant matters and inquired with the Company's controlling shareholder. The relevant situation is hereby explained as follows:

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.